Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Hasbani: We Developed a Comprehensive Health System so as not to Exclude any Citizen from the Universal Coverage

 
NNA- The administration and justice committee held a meeting presided by Deputy Robert Ghanem in the presence of Deputy Prime Minister Health Minister Ghassan Hasbani and deputies: Hani Kobaisy, Elie Aoun, Serge Torsarkisian, Atef Majdalani, Ghassan Moukhayber, Nawaf Mousawi, the representatives of Health Ministry Fadi Mosallem and the Ministry of Social Affairs Adnan Naser Eddine, Director General of the National Social Security Fund Dr. Muhammad Karaki, Head of NSSF Diwan Chawki Abou Nassif, the representative of the Ministry of Finance Nahla Boustani, the President of the General Confederation of Lebanese Workers Bechara Asmar.

Ghanem

“This is the eighth meeting of the administration and justice committee to study the so-called visa coverage card; the mandatory universal healthcare coverage suggested by Dr Atef Majdalani and studied by the Health committee. When H.E. Hasbani became Health Minister, he asked that this subject be more comprehensive. A study was conducted to include the majority of the Lebanese citizens,” stated the committee’s president.

Hasbani

“I would like to thank and congratulate the administration and justice committee for discussing the proposal of the law submitted by Deputy Atef Majdalani. The Ministry of Public Health made observations based on a recent study this year on the health coverage or the mandatory universal health care. The detailed study with experts includes many observations made on this subject to develop the system so as not to exclude any citizen from the universal coverage; primary health care, inpatient and outpatient services,” outlined Hasbani.

Majdalani

“I would like to thank my colleague Mr. Robert Ghanem, the president of the administration and justice committee for his help and seriousness in scheduling the meetings of the committee and contribution in the discussions. I thank as well Health Minister Ghassan Hasbani for the amendments of Health Ministry to expand the network of social and health solidarity in the proposal of the law we suggested in 2013,” said Majdalani.
    ...
    179
    ...
ATC Name B/G Ingredients Dosage Form Price
B01AF01 XAVIRAN G Rivaroxaban - 20mg 20mg Tablet, film coated 952,208 L.L
B01AF01 XAVIRAN G Rivaroxaban - 10mg 10mg Tablet, film coated 606,649 L.L
B01AF01 XAVIRAN G Rivaroxaban - 15mg 15mg Tablet, film coated 952,208 L.L
L04AA29 XELJANZ B Tofacitinib - 5mg 5mg Tablet 80,685,473 L.L
L04AA29 XELJANZ XR B Tofacitinib - 11mg 11mg Tablet, extended release 78,687,316 L.L
L01BC06 XELODA B Capecitabine - 500mg 500mg Tablet, film coated 17,946,398 L.L
D07AC13 XEMADERM G Mometasone furoate - 0.1% 0.1% Cream 335,961 L.L
A08AB01 XENICAL B Orlistat - 120mg 120mg Capsule 4,036,903 L.L
M03AX01 XEOMIN BioTech Clostridium botulinum type A neurotoxin complex - 100 units LD50 100 units LD50 Injectable powder for solution 20,517,541 L.L
M03AX01 XEOMIN BioTech Clostridium botulinum type A neurotoxin complex - 50 units LD50 50 units LD50 Injectable powder for solution 11,920,109 L.L
J01DD15 XEVANEER G Cefdinir - 125mg/5ml 125mg/5ml Powder for suspension 1,308,903 L.L
J01DD15 XEVANEER G Cefdinir - 125mg/5ml 125mg/5ml Powder for suspension 686,704 L.L
J01DD15 XEVANEER G Cefdinir - 300mg 300mg Capsule 1,350,562 L.L
M05BX04 XGEVA BioTech Denosumab - 120mg 120mg Injectable solution 33,545,669 L.L
A10BD15 XIGDUO XR B Metformin HCl XR - 1000mg, Dapagliflozin - 5mg Tablet 3,867,041 L.L
A10BD15 XIGDUO XR B Metformin HCl XR - 1000mg, Dapagliflozin - 10mg Tablet 3,006,579 L.L
H02AB06 XILONE FORTE G Prednisolone sodium phosphate - 15mg/5ml 15mg/5ml Solution 413,903 L.L
C10AX09 XIMACOL G Ezetimibe - 10mg 10mg Tablet 1,894,818 L.L
R03DX05 XOLAIR BioTech Omalizumab - 150mg 150mg Injectable lyophilised powder for solution+diluent 54,613,625 L.L
R03DX05 XOLAIR BioTech Omalizumab - 150mg 150mg Injectable solution 37,110,724 L.L
S01ED51 XOLAMOL G Timolol (maleate) - 5mg/ml, Dorzolamide HCl - 20mg/ml Drops solution 678,640 L.L
L02BB04 XTANDI B Enzalutamide - 40mg 40mg Capsule, soft 278,248,572 L.L
A10AE56 XULTOPHY BioTech Insulin degludec - 100U/ml, Liraglutide - 3.6mg/ml Injectable solution 13,503,847 L.L
A10AE56 XULTOPHY BioTech Insulin degludec - 100U/ml, Liraglutide - 3.6mg/ml Injectable solution 13,503,847 L.L
R01AA07 XYLO-COMOD G Xylometazoline HCl - 0.1% 0.1% Solution 499,909 L.L
D04AB01 XYLOCAINE B Lidocaine - 10mg/spray dose 100mg/ml Spray 667,890 L.L
B02BD02 XYNTHA BioTech Moroctocog alfa - 500IU 500IU Injectable lyophilised powder for solution+diluent 23,067,288 L.L
B02BD02 XYNTHA BioTech Moroctocog alfa - 500IU 500IU Injectable lyophilised powder for solution+diluent L.L
R06AE09 XYZAL B Levocetirizine dihydrochloride - 5mg 5mg Tablet, film coated 572,477 L.L
J01CR05 YANOVEN G Piperacillin (sodium) - 2g, Tazobactam (sodium) - 0.25g Injectable powder for solution+diluent 830,623 L.L
    ...
    179
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025